Whipplewood Advisors’s AbbVie ABBV Stock Holding History

Whipplewood Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.4K	Sell	101 -177	-64%	-$38.1K	0.02%	178
2026 Q1	$60.5K	Sell	278 -552	-67%	-$122K	0.03%	247
2025 Q4	$190K	Buy	830 +13	+2%	+$2.96K	0.12%	123
2025 Q3	$189K	Sell	817 -281	-26%	-$57.2K	0.12%	124
2025 Q2	$204K	Sell	1,098 -1,240	-53%	-$230K	0.11%	164
2025 Q1	$228K	Buy	2,338 +1,256	+116%	+$244K	0.13%	144
2024 Q4	$192K	Buy	+1,082	New	+$199K	0.11%	161

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Whipplewood Advisors's ABBV Position: Q2 2026 in Review

Whipplewood Advisors reduced its AbbVie (ABBV) stake by 64% in Q2 2026, selling an estimated $38.1K and leaving 101 shares worth $25.4K. The position accounts for 0.02% of the portfolio, ranked #178.

Whipplewood Advisors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $228K in Q1 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Whipplewood Advisors held 101 shares of AbbVie worth $25.4K as of Q2 2026.
Whipplewood Advisors sold 177 AbbVie shares in Q2 2026, an estimated $38.1K.
AbbVie made up 0.02% of Whipplewood Advisors's portfolio in Q2 2026, its #178 holding.
Whipplewood Advisors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
Whipplewood Advisors's AbbVie position peaked at $228K in Q1 2025.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.